Carmell - CTCX Total Company Value-to-Revenue Ratio

Public company logo of carmellrx.com (CTCX)

The EV/Revenue multiple provided by the GURU.Markets terminal demonstrates the share price's dependence on the success of plasma technologies and patents, with serving as the current value of this metric. The strategy of Carmell Corporation (CTCX) is based on capturing the pharmaceutical market through bioactive materials; however, the transition to bio-cosmetics requires massive marketing expenditures, while current losses are reducing the organization's overall liquidity.

CTCX Carmell Corporation: Enterprise Value-to-Revenue Ratio in the range 07/04/2022 - 11/20/2026

Carmell Corp. - analytical breakdowns and key metrics (CTCX)

- money and cash flow information:
Initial company analysis:carmellrx.com CTCX
Manufactured product of Carmell

This indicator reflects the total enterprise value, including debt and cash, per unit of revenue, allowing for an assessment of the market value of assets regardless of capital structure. By analyzing the EV/Sales ratio trend, an investor can see how the risk of Carmell Corporation (CTCX) shifting its profile toward bio-cosmetics and the associated losses impact the market's perception of the efficiency of generated sales.

Competitor analysis

ASND: Enterprise Value-to-Revenue Ratio|MDGL: EV/Sales Multiple|CORT - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Rhythm Corp|Akero Corp (AKRO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio metsera.com (MTSR)|Company Value to Revenue moonlaketx.com MLTX|EV/Sales Multiple CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Company Value to Revenue Ratio|SLNO - Enterprise Value-to-Revenue Ratio|Amicus Pharma (FOLD) - Company Value to Revenue|ETNB: EV/Sales Multiple|AGIO - Total Company Value-to-Revenue Ratio|Company Value to Revenue GPCR|Enterprise Value-to-Revenue Multiple MiMedx MDXG|Enterprise Value-to-Revenue Ratio Rezolute Corp (RZLT)|Company Value to Revenue Lexicon Corp LXRX|Enterprise Value-to-Revenue Ratio MBX Biosciences, Inc. MBX|EV/Sales Multiple altimmune.com ALT|AARD - Enterprise Value-to-Revenue Ratio|Sagimet - Enterprise Value-to-Revenue Coefficient|BioAge Labs Inc. (BIOA) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - EV/Sales Multiple|GUTS: Business Value to Revenue|Enterprise Value-to-Revenue Ratio vtvtherapeutics.com (VTVT)|ATPC (Agape ATP) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Pluristem Therapeutics PLUR|SYBX: Company Value to Revenue Ratio|lipocine.com - EV/Sales Multiple|Enterprise Value to Sales Volume MTNB|SPRB: EV/Sales Multiple|Enterprise Value-to-Sales Ratio Galecto Inc GLTO|LUMO (Lumos Therapeutics) - EV/Sales Multiple|Organovo Corp (ONVO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Radius Recycling (RDUS)